These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15132956)

  • 1. Treatment of multidrug-resistant tuberculosis: should you try this at home?
    Griffith DE
    Am J Respir Crit Care Med; 2004 May; 169(10):1082-3. PubMed ID: 15132956
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis.
    Chan ED; Laurel V; Strand MJ; Chan JF; Huynh ML; Goble M; Iseman MD
    Am J Respir Crit Care Med; 2004 May; 169(10):1103-9. PubMed ID: 14742301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis.
    Törün T; Tahaoğlu K; Ozmen I; Sevim T; Ataç G; Kir A; Güngör G; Bölükbaşi Y; Maden E
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):979-85. PubMed ID: 17705975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of tuberculosis].
    Eier A; Grass S
    Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistant tuberculosis.
    Millard J; Ugarte-Gil C; Moore DA
    BMJ; 2015 Feb; 350():h882. PubMed ID: 25721508
    [No Abstract]   [Full Text] [Related]  

  • 8. PAS infusion in treatment of multidrug-resistant tuberculosis.
    Fodor T; Pataki G; Schrettner M
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):187-8. PubMed ID: 10694102
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose fluoroquinolones in short-course regimens for treatment of MDR-TB: the way forward?
    Yew WW; Nuermberger E
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):853-4. PubMed ID: 23743304
    [No Abstract]   [Full Text] [Related]  

  • 10. How are we creating fluoroquinolone-resistant tuberculosis?
    Bernardo J; Yew WW
    Am J Respir Crit Care Med; 2009 Aug; 180(4):288-9. PubMed ID: 19661251
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis.
    Shin SS; Hyson AM; Castañeda C; Sánchez E; Alcántara F; Mitnick CD; Fawzi MC; Bayona J; Farmer PE; Kim JY; Furin JJ
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):347-53. PubMed ID: 12729340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 13. Childhood tuberculosis: treatment strategies and recent advances.
    Starke JR
    Paediatr Respir Rev; 2001 Jun; 2(2):103-12. PubMed ID: 12531056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Gupta R; Espinal MA; Raviglione MC
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug resistant tuberculosis.
    Singh M; Jayanthi S; Kumar L
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S41-6. PubMed ID: 11129907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].
    Ogawara M; Sakatani M
    Kekkaku; 1998 Nov; 73(11):673-7. PubMed ID: 9866930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolones and dairy intake: dogma or evidence? Considerations on the short-course regimen for children.
    Monedero I; Macias CP
    Int J Tuberc Lung Dis; 2017 Dec; 21(12):1316-1317. PubMed ID: 29297456
    [No Abstract]   [Full Text] [Related]  

  • 19. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
    Veen J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
    [No Abstract]   [Full Text] [Related]  

  • 20. [The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis].
    Iwanaga T; Yokota K; Kishikawa R; Ikeda T; Tsurutani H; Hirose T; Nishima S
    Kekkaku; 1997 Jan; 72(1):9-13. PubMed ID: 9038010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.